(Q38869433)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27318684%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

review article

1 reference

title

Hypoxia as a Biomarker and for Personalized Radiation Oncology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27318684%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27318684%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Dirk Vordermark

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27318684%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

1 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27318684%20AND%20SRC:MED&resulttype=core&format=json

Recent Results in Cancer Research

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27318684%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27318684%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

123-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27318684%20AND%20SRC:MED&resulttype=core&format=json

Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Oxygenation predicts radiation response and survival in patients with cervix cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Hyperthermia: a potent enhancer of radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Imaging hypoxia to improve radiotherapy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Electron paramagnetic resonance imaging of tumor pO₂.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Transcriptional response to hypoxia in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Comparison of 18F-Fluoroerythronitroimidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography and Prognostic Value in Locally Advanced Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Assessment of tumor hypoxia by 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluoresce

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Hypoxic radiosensitization: adored and ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Imaging tumor hypoxia by magnetic resonance methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Influence of oxygen concentration and pH on expression of hypoxia induced genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Strategies for biologic image-guided dose escalation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Clinical applications of EPR: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Measurements of tumor tissue oxygen tension using a time-resolved luminescence-based optical oxylite probe: comparison with a paired survival assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

PET imaging of hypoxia using [18F]HX4: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Methods for noninvasive imaging of tissue hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Comparison of Helzel and OxyLite systems in the measurements of tumor partial oxygen pressure (pO2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Measuring tumor hypoxia with ¹⁸F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Tumor physiologic response to combretastatin A4 phosphate assessed by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Measurement of Tumor Oxygenation: A Comparison between Polarographic Needle Electrodes and a Time-Resolved Luminescence-Based Optical Sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

The relation between hypoxia-inducible factor (HIF)-1α and HIF-2α expression with anemia and outcome in surgically treated head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-662-49651-0_6

10.1007/978-3-662-49651-0_6

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27318684%20AND%20SRC:MED&resulttype=core&format=json

release_mginc6m3mfditeaprewekeo5nu

14 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mginc6m3mfditeaprewekeo5nu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference